ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Disease Activity"

  • Abstract Number: 160 • 2016 ACR/ARHP Annual Meeting

    Ultrasound Assessment of Rheumatoid Arthritis Patients. External Validation and Inter-Rater Reliability of a 4-Joint Ultrasonographic Scoring System

    Tomas Cazenave1, María Victoria Martire2,3, Christian A. Waimann4,5, Javier Rosa6, Marcelo Audisio7, Ana Bertoli8, Guillermo Py9, Santiago Ruta6, Josefina Marin10, Johana Zacariaz6, Cristian Troitiño11, Mariana Benegas12, Lida Santiago13, Patricio Tate14, Walter J. Spindler15, Horacio Berman16, María Julia Santa Cruz17, Paula Kohan18, Silvia Beatriz Papasidero19, Gustavo Citera20 and Marcos G. Rosemffet1, 1Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, 3Rheumatology, Hospital Italiano de La Plata, La Plata, Argentina, 4Escuela Superior de Ciencias de la Salud, UNICEN., Olavarria,, Argentina, 5Rheumatology, Hospital Dr. Hector Cura, Olavarria, Argentina, 6Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 7Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba, Argentina, 8Instituto Reumatológico Strusberg, Córdoba, Argentina, 9Servicio de Reumatología del Hospital Nacional de Clínicas, Córdoba., Cordoba, Argentina, 10Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 11Reumatologia, Hospital Bernardino Rivadavia, CAPITAL FEDERAL, Argentina, 12PSORIAHUE, Buenos Aires, Argentina, 13Organizacion Medica de Investigacion, Buenos Aires, Argentina, 14Organizacion Médica de Investigación, Buenos Aires, Argentina, 15Centro Médico Privado de Reumatología, Tucuman, Argentina, 16Centro Médico Privado de Reumatología, Tucumán, Argentina, 17Hospital Dr. E. Tornú, Buenos Aires, Argentina, 18Hospital Dr. E. Tornu, Buenos Aires, Argentina, 19Rheumatology Department, Rheumatology Unit, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 20Rheumatology Section, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Although Ultrasound (US) has demonstrated to be a sensitive and specific tool, its feasibility in daily clinical practice is still under debate. We have…
  • Abstract Number: 2 • 2015 ACR/ARHP Annual Meeting

    The Neutrophil Protein S100A12 Has Stronger Associations with a Comprehensive Ultrasound Score of Synovitis Than Vascular Endothelial Growth Factor in a Longitudinal Study of Rheumatoid Arthritis Patients

    Hilde Haugedal Nordal1,2 and Hilde Berner Hammer3, 1Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, 2Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: S100A12, a neutrophil protein, has proinflammatory effects on immune cells and can activate endothelial cells. The mechanism of action suggests vascular endothelial growth factor…
  • Abstract Number: 171 • 2015 ACR/ARHP Annual Meeting

    Serum Calprotectin Levels Correlate with Ultrasonographic Synovitis in Rheumatoid Arthritis Patients

    Jana Hurnakova1, Jakub Zavada1, Petra Hanova1, Hana Hulejová1, Martin Klein1, Herman F Mann1, Olga Sleglova1, Marta Olejarova1, Šárka Forejtová1, Olga Ruzickova1, Martin Komarc2, Jiri Vencovsky1, Karel Pavelka1 and Ladislav Senolt1, 1Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Biophysics and Informatics of the First Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: Calprotectin (S100A8/9, MRP8/14) has been demonstrated as a promising biomarker of clinical and laboratory disease activity in rheumatoid arthritis (RA). In addition, two small…
  • Abstract Number: 535 • 2015 ACR/ARHP Annual Meeting

    Taurine As a Biomarker for Prediction of Response to Biologic Therapy in Rheumatoid Arthritis

    Soshi Takahashi1, Jun Saegusa2, Ikuko Naka1, Kosaku Tsuda1, Takaichi Okano1, Kengo Akashi1, Miwa Nishida1, Keisuke Nishimura2, Sho Sendo2, Yo Ueda1, Akira Onishi3, Yoshinori Kogata2, Goichi Kageyama2 and Akio Morinobu2, 1Department of Rheumatology, Kobe University Hospital, Kobe, Japan, 2Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 3Rheumaology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan

    Background/Purpose: To identify a serum biomarker for prediction of the response to biologics (Bio) in patients with rheumatoid arthritis (RA), we performed serum metabolomics analysis…
  • Abstract Number: 757 • 2015 ACR/ARHP Annual Meeting

    The Ratio Between TNF-a and P-Albumin – a Suggested Measure of Disease Activity in SLE

    Susanna Eketjäll1, Helena Idborg2, Johanna Gustafsson3, Agneta Zickert2, Marika Kvarnstrom4, Vilija Oke5, Susanne Pettersson4, Per Johan Jakobsson4, Iva Gunnarsson4 and Elisabet Svenungsson4, 1Department of Clinical Neuroscience, Karolinska Institutet, Solna, AstraZeneca Translational Sciences Centre, Science for Life Laboratory, Personal Healthcare and Biomarkers, Stockholm, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 4Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 5Department of medicine, Unit of Rheumatology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: There is presently no consensus on how to best measure disease activity in systemic lupus erythematosus (SLE). Available validated measures, such as SLE Disease…
  • Abstract Number: 1560 • 2015 ACR/ARHP Annual Meeting

    The Effect of Anti Estrogen Therapy (AET) on Rheumatoid Arthritis

    Bassam Alhaddad1, Amrita Kaur Bath2, Bassem Zraik3, Mohamed Alalwani4 and Stanley P Ballou1, 1Rheumatology, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH, 2Internal medicine, Fairview Hospital- Cleveland Cinic, Cleveland, OH, 3Internal Medicine, Fairview Hospital- Cleveland Clinic, cleveland, OH, 4Hospital Medicine, Cleveland Clinic, Cleveland, OH

    Background/Purpose: The well-known positive effect of pregnancy on improving Rheumatoid Arthritis (RA) disease activity suggests that hormonal changes may play a role in disease pathogenesis…
  • Abstract Number: 2277 • 2015 ACR/ARHP Annual Meeting

    Working Harder to Stay in Control: Patient Reports of Flare in Early RA Are Associated with Higher Disease Activity and More Intensive Self Management

    Susan J. Bartlett1,2, Clifton O. Bingham III3, Daming Lin4, Kathleen Andersen5, Gilles Boire6, Carol Hitchon7, Boulos Haraoui8, Edward C. Keystone9, Diane Tin10, J Carter Thorne11, Janet E. Pope12, VP Bykerk4 and CATCH Investigators and OMERACT Flare Group, 1Clinical Epidemiology, McGill University, Montreal, QC, Canada, 2Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, 3Rheumatology, Johns Hopkins University, Baltimore, MD, 4Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 5Hospital for Special Surgery, New York, NY, 6Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 7Department of Rheumatology, University of Manitoba, Winnipeg, MB, Canada, 8Institut de Rhumatologie, Montreal, QC, Canada, 9Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 10The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, 11University of Toronto, Toronto, ON, Canada, 12University of Western Ontario, London, ON, Canada

    Background/Purpose: Early rheumatoid arthritis (ERA) patients attending office visits often report being in a disease flares. We evaluated patient reports of flare in relation to…
  • Abstract Number: 2589 • 2015 ACR/ARHP Annual Meeting

    Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis

    Christian G. Ammitzbøll1, Rudi Steffensen2, Martin Bøgsted3,4, Kaspar Rene Nielsen2, Torkell Ellingsen5, Merete Lund Hetland6, Peter Junker5, Jan Pødenphant7, Mikkel Østergaard8, Julia Johansen9, Kim Hørslev-Petersen10 and Kristian Stengaard-Pedersen1, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Department of Haematology, Aalborg University Hospital, Aalborg, Denmark, 4Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark, Aalborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, Denmark, 6DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Glostrup, Denmark, 7Department of Rheumatology, Copenhagen University Hospital at Gentofte, Glostrup, Denmark, 8Rigshospitalet-Glostrup, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Glostrup, Denmark, 9Departments of Medicine and Oncology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark, 10Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Graasten, Denmark

    Background/Purpose: Genome-wide association studies (GWAS) and meta-GWAS studies have identified >50 single nucleotide-polymorphisms (SNPs) that are associated with susceptibility to rheumatoid arthritis (RA). It is,…
  • Abstract Number: 2675 • 2015 ACR/ARHP Annual Meeting

    Has the Relationship Between Disease Activity and Disability in Rheumatoid Arthritis Changed?

    Aneela Mian1, Fowzia Ibrahim2,3, Ian C. Scott4, Sardar Bahadur5, Maria Filkova6, Louise Pollard7, Gabrielle H. Kingsley8, Sophia Steer9, David L. Scott6 and James Galloway10, 1Academic Rheumatology, King's College London, London, United Kingdom, 2Academic Rheumatology Dept, King's College, London, United Kingdom, 3Academic Rheumatology Dept, King's College London, London, United Kingdom, 4Louise Coote Lupus Unit, St Thomas' Hospital, London, United Kingdom, 5Guys' and St Thomas' NHS Trust, London, United Kingdom, 6Academic Department of Rheumatology, King´s College London, London, United Kingdom, 7University Hospital Lewisham, London, United Kingdom, 8Rheumatology, Kings College London, London, United Kingdom, 9Rheumatology Dept, Kings College Hospital, London, United Kingdom, 10King's College Hospital, London, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) management paradigms have changed over the last two decades. Evidence now supports aggressive immunosuppression with early use of combination disease modifying…
  • Abstract Number: 3080 • 2015 ACR/ARHP Annual Meeting

    Histone H2AX Phosphorylation As a Measure of DNA Double Strand Breaks and a Marker of Environmental Stress and Disease Activity in Lupus

    Rajaie Namas, Paul Renauer, Mikhail Ognenovski, Pei-Suen Tsou and Amr H. Sawalha, Division of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Studies suggested that defective or inefficient DNA double strand break (DSB) repair results in failure to preserve genomic integrity leading to apoptotic cell death,…
  • Abstract Number: 46 • 2015 ACR/ARHP Annual Meeting

    Feasibility Study of Smartphone Data Collection for Cloudy with a Chance of Pain: Sustained Engagement for Daily Self-Reporting of Disease Severity in Rheumatoid Arthritis over Two Months

    Samuel Reade1, Jamie C Sergeant2,3, Matthew Sperrin4, David M. Schultz5, Karen Spencer6, Caroline Sanders6 and William G Dixon7, 1The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom, 4Institute of Population Health, Health e-Research Centre, The University of Manchester, Manchester, United Kingdom, 5Faculty of Engineering and Physical Sciences, School of Earth, Atmospheric and Environmental Sciences, The University of Manchester, Manchester, United Kingdom, 6Institute of Population Health, Centre for Primary Care, The University of Manchester, Manchester, United Kingdom, 7Manchester Academic Health Sciences Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Previous research has attempted to study the association between weather and joint pain. Inconclusive results may be due, in part, to infrequent measures of…
  • Abstract Number: 172 • 2015 ACR/ARHP Annual Meeting

    Prospective Assessment of Carotid Intima Media Thickness in Relation to Activity of the Disease in Patients with Rheumatoid Arthritis

    Bozena Targonska-Stepniak1, Mariusz Piotrowski1, Robert Zwolak2 and Maria Majdan3, 1Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland, Lublin, Poland, 2Rheumatologyand Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland, 3Department of Rheumatology and Connective Tissue Diseases, Medical University in Lublin, Poland, Lublin, Poland

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease that is complicated by accelerated atherosclerosis associated with the risk of adverse cardiovascular (CV) events and…
  • Abstract Number: 541 • 2015 ACR/ARHP Annual Meeting

    Microrna-125b Expression in PBMCs Is Associated with Disease Activity in Patients with Early Rheumatoid Arthritis

    Veronika Hruskova1,2, Romana Jandová3, Lucia Vernerova4, Herman F Mann5, Klára Prajzlerová4, Maria Filkova4, Karel Pavelka5, Jiri Vencovsky5 and Ladislav Senolt5, 1Institute of Rheumatology and Department of Rheumatology; Faculty of Science Charles University, Prague, Czech Republic, 2Faculty of Science, Charles University, Prague, Czech Republic, 3Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic, 4Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, 5Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: MicroRNAs (miRNAs) are small non-coding RNAs that function as negative regulators of gene expression at posttranscription level and play a significant role in rheumatoid…
  • Abstract Number: 771 • 2015 ACR/ARHP Annual Meeting

    Convergent Validity of New Disease Assessment Instruments in Systemic Lupus Erythematosus in Relation to Sledai-2K

    Christopher Collins1, W. Winn Chatham2, Howard Busch3, Norman B. Gaylis4, Emily Hautamaki5 and Siva Narayanan6, 1MedStar Washington Hospital Center, Washington, DC, 2Medicine/Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Science & Research Institute, Jupiter, FL, 4Arthritis & Rheumatic Disease Specialties, Aventura, FL, 5Ipsos Healthcare, Washington, DC, 6Global Evidence, Value and Access, Ipsos Healthcare, Washington, DC

    Background/Purpose: Current validated disease assessment instruments (DAIs) in systemic lupus erythematosus (SLE) such as SLEDAI-2K and BILAG, require disease expertise and/or involve complex scoring systems,…
  • Abstract Number: 1579 • 2015 ACR/ARHP Annual Meeting

    Association of Myocardial Abnormalities with N-Terminal Pro-Brain Natriuretic Peptide and Disease Activity in Rheumatoid Arthritis without Cardiac Symptoms, Assessed By Cardiac Magnetic Resonance Imaging

    Hitomi Kobayashi1, Yasuyuki Kobayashi2, Isamu Yokoe3, Natsumi Ikumi4,5, Hirotake Inomata6, Atsuma Nishiwaki6, Noboru Kitamura1, Kaita Sugiyama6, Hidetake Shiraiwa6, Masataka Nozaki6, Yosuke Nagasawa6, Yoshihiro Matsukawa5 and Masami Takei1, 1Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 2Advanced Biomedical Imaging Informatics, St.Marianna University School of Medicine, Kawasaki, Japan, 3Rheumatology, Itabashi Chuo Medical Center, Tokyo, Japan, 4Nihon University School of Medicine, Shinjuku, Japan, 5Division of Heamatology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 6Nihon University School of Medicine, Tokyo, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is a multi-organ inflammatory disorder associated with high cardiovascular morbidity and mortality. Cardiac involvements are typically clinically silent, only manifesting as…
  • « Previous Page
  • 1
  • …
  • 86
  • 87
  • 88
  • 89
  • 90
  • …
  • 112
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology